Does clustering affect the usual test statistics of no treatment effect in a randomized clinical trial?

Biometrical Journal

Volumn 40, Issue 4, 1998, Pages 385-402

  Parzen, Michael ^a   Lipsitz, Stuart R ^b   Dear, Keith B G ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Graduate School of Business ^*

Author keywords

Binary data; Regression; Two sample t test

Indexed keywords

MEDICAL APPLICATIONS; STATISTICAL TESTS; STATISTICS;

BINARY DATA; CLINICAL TRIAL; CLUSTERINGS; RANDOMIZED CLINICAL TRIALS; REGRESSION; TEST STATISTICS; TREATMENT EFFECTS; TWO SAMPLE T TESTS;

HOSPITALS;

EID: 0032395599     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4036(199808)40:4<385::aid-bimj385>3.0.co;2-%23     Document Type: Article

References (3)

1. FALKSON, G., CNAAN, A., SIMSON, I. W. et al., 1990: A randomized Phase II study of acivicin and 4'Deoxydorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group Study. American Journal of Clinical Oncology 13, 510-515.
2. LIANG, K. Y. and ZEGER, S. L., 1986: Longitudinal data analysis using generalized linear models. Biometrika 73, 13-22.
3. MANTEL, N. and HAENSZEL, W., 1959: Statistical aspects of analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 73, 719-748.